These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
996 related articles for article (PubMed ID: 18047543)
1. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543 [TBL] [Abstract][Full Text] [Related]
2. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins? Lakatos PL; Altorjay I; Mándi Y; Lakatos L; Tumpek J; Kovacs A; Molnar T; Tulassay Z; Miheller P; Palatka K; Szamosi T; Fischer S; Papp J; ; Papp M Tissue Antigens; 2008 Jun; 71(6):552-9. PubMed ID: 18397186 [TBL] [Abstract][Full Text] [Related]
3. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801 [TBL] [Abstract][Full Text] [Related]
4. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856 [TBL] [Abstract][Full Text] [Related]
5. Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort. Malickova K; Lakatos PL; Bortlik M; Komarek V; Janatkova I; Lukas M Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):144-50. PubMed ID: 19927001 [TBL] [Abstract][Full Text] [Related]
6. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [TBL] [Abstract][Full Text] [Related]
7. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Ferrante M; Henckaerts L; Joossens M; Pierik M; Joossens S; Dotan N; Norman GL; Altstock RT; Van Steen K; Rutgeerts P; Van Assche G; Vermeire S Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509 [TBL] [Abstract][Full Text] [Related]
8. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Arnott ID; Landers CJ; Nimmo EJ; Drummond HE; Smith BK; Targan SR; Satsangi J Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586 [TBL] [Abstract][Full Text] [Related]
9. Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort. Papp M; Lakatos PL; Harsfalvi J; Farkas G; Palatka K; Udvardy M; Molnar T; Farkas K; Nagy F; Veres G; Lakatos L; Kovacs A; Dinya T; Kocsis AK; Papp J; ; Altorjay I Hum Immunol; 2010 Apr; 71(4):407-13. PubMed ID: 20079790 [TBL] [Abstract][Full Text] [Related]
10. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study. Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. Lakatos PL; Altorjay I; Szamosi T; Palatka K; Vitalis Z; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Barta Z; Stocker W; Papp J; Veres G; Papp M; Inflamm Bowel Dis; 2009 Mar; 15(3):365-74. PubMed ID: 18972554 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542 [TBL] [Abstract][Full Text] [Related]
14. New serologic markers for inflammatory bowel disease diagnosis. Dotan I Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866 [TBL] [Abstract][Full Text] [Related]
15. 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population. Marrakchi R; Bougatef K; Moussa A; Ouerhani S; Khodjet-el-Khil H; Messai Y; Mestiri O; Najar T; Benammar-Elgaaeid A Inflamm Res; 2009 Apr; 58(4):218-23. PubMed ID: 19184350 [TBL] [Abstract][Full Text] [Related]
16. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course. Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876 [TBL] [Abstract][Full Text] [Related]
17. [Relevance of serologic studies in inflammatory bowel diseases]. Papp M; Altorjay I; Lakatos PL Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404 [TBL] [Abstract][Full Text] [Related]
18. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis. Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205 [TBL] [Abstract][Full Text] [Related]
20. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study]. Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F; Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]